Retroviruses and CFS/ME: The Epigenetic Battle for Mitochondrial Health

Quick Answer: How Might Retroviruses Influence Chronic Fatigue?

Human Endogenous Retroviruses (HERVs) are ancient viral sequences integrated into the human genome. Under normal conditions, these sequences remain epigenetically silenced, particularly through DNA methylation. Emerging research suggests that in some individuals with treatment-resistant Chronic Fatigue Syndrome (CFS/ME), dysregulation of these control mechanisms may be associated with immune activation, systemic inflammation, mitochondrial stress, and altered cerebral blood flow. These processes overlap with many of the hallmark features observed in CFS/ME (1,5,11).

Core Concept: Endogenous Retroviruses and Epigenetic Control

HERVs entered the human genome millions of years ago and now make up a substantial proportion of human DNA. While most are inactive, their expression is regulated by epigenetic mechanisms that prevent inappropriate transcription. DNA methylation acts as a primary “silencing” signal, limiting access to these viral sequences. When epigenetic regulation is impaired, increased HERV expression has been observed in several chronic inflammatory and neurological conditions (1,9,10).

The Mechanism: Epigenetic Silencing and Immune Stress

Epigenetic instability, including hypomethylation, has been proposed as one factor that may permit increased transcription of endogenous retroviral elements. Variations in methylation capacity, oxidative stress, and immune activation may all influence this process. Importantly, HERV expression does not equate to infection but may contribute to immune signalling and inflammatory cascades that strain mitochondrial energy production (4,5).

The Hypoxic Brain: Neuroinflammation and Cerebral Blood Flow

Cognitive dysfunction or “brain fog” is a common and disabling symptom of CFS/ME. Research suggests that chronic immune activation may contribute to endothelial inflammation, impairing cerebral blood flow and oxygen delivery. This form of neuro-inflammation has been associated with reduced cognitive performance and fatigue severity in observational studies of CFS/ME (11,18).

Clinical Testing Considerations

In integrative clinical settings, practitioners may explore patterns of immune activation, inflammatory signalling, and metabolic stress when evaluating complex fatigue presentations. Some experimental biomarkers have been discussed in the research literature; however, these are not diagnostic and must be interpreted cautiously alongside validated investigations and clinical context (13).

Next Steps

For individuals experiencing persistent fatigue that has not responded to standard approaches, a deeper assessment of immune, metabolic, and epigenetic factors may be warranted. This approach focuses on understanding patterns rather than isolated test results and aims to clarify contributors to ongoing symptom burden.

Key Insights

• Human endogenous retroviruses are a normal part of human DNA and are usually epigenetically silenced (1,9).
• Altered regulation of these sequences has been observed in chronic inflammatory and neurological conditions, including CFS/ME (10,11).
• Immune activation, mitochondrial stress, and impaired cerebral blood flow may represent overlapping pathways contributing to fatigue and cognitive symptoms (5,18).

Restore Your Energy Balance

If you are living with unexplained or treatment-resistant fatigue, a comprehensive, mechanism-informed assessment may help clarify contributing factors. To explore this approach, you can book a CFS consultation with Elemental Health and Nutrition in Adelaide.

References

1. Grandi N, Tramontano E. Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses. Front Immunol. 2018;9:2039.
2. Coffin JM, Hughes SH, Varmus HE. Retroviruses. Cold Spring Harbor Laboratory Press; 1997.
3. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014;16:7–17.
4. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484–492.
5. Naviaux RK et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016;113(37):E5472–E5480.
6. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and other neurological diseases. J Neurovirol. 2010;16(6):445–457.
7. Douville R et al. Human endogenous retrovirus-K correlates with disease severity in ALS. Ann Neurol. 2011;69(1):141–151.
8. Komaroff AL, Bateman L. Will COVID-19 lead to ME/CFS? Front Med. 2021;7:606824.
9. Rowe PC et al. Orthostatic intolerance and cerebral blood flow in ME/CFS. Front Pediatr. 2018;6:373.
10. Wirth K, Scheibenbogen C. A unifying hypothesis of ME/CFS. Autoimmun Rev. 2020;19(9):102527.
11. Houghton CA. Sulforaphane: its “coming of age” as a clinically relevant nutraceutical. Oxid Med Cell Longev. 2019;2019:2716870.
12. Yamamoto N et al. Deglycosylation of serum vitamin D-binding protein and macrophage activation. Cancer Immunol Immunother. 2008;57(5):689–699.
13. Pall ML. Electromagnetic fields act via activation of voltage-gated calcium channels. J Cell Mol Med. 2013;17(8):958–965.
14. Zhang Y et al. A major inducer of anticarcinogenic protective enzymes from broccoli. Proc Natl Acad Sci USA. 1992;89(6):2399–2403.
15. Exley C. Aluminum and medicine. Mol Biol Alum. 2011;1:1–16.